ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 166 filers reported holding ANTARES PHARMA INC in Q3 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $23,000 | -72.3% | 5,700 | -75.7% | 0.00% | – |
| Q4 2021 | $83,000 | 0.0% | 23,494 | +3.2% | 0.00% | – |
| Q3 2021 | $83,000 | -19.4% | 22,775 | -3.7% | 0.00% | – |
| Q2 2021 | $103,000 | -55.2% | 23,655 | -57.9% | 0.00% | – |
| Q1 2021 | $230,000 | -54.3% | 56,141 | -55.5% | 0.00% | – |
| Q4 2020 | $503,000 | +528.8% | 126,133 | +325.9% | 0.00% | – |
| Q3 2020 | $80,000 | -72.4% | 29,614 | -71.8% | 0.00% | – |
| Q2 2020 | $290,000 | -9.4% | 105,139 | -22.3% | 0.00% | – |
| Q1 2020 | $320,000 | -67.3% | 135,360 | -35.0% | 0.00% | – |
| Q4 2019 | $979,000 | +125.1% | 208,200 | +60.4% | 0.00% | – |
| Q3 2019 | $435,000 | +162.0% | 129,824 | +157.2% | 0.00% | – |
| Q2 2019 | $166,000 | +31.7% | 50,480 | +21.8% | 0.00% | – |
| Q1 2019 | $126,000 | -41.9% | 41,456 | -48.0% | 0.00% | – |
| Q4 2018 | $217,000 | +57.2% | 79,694 | +94.4% | 0.00% | – |
| Q3 2018 | $138,000 | +155.6% | 40,995 | +96.0% | 0.00% | – |
| Q2 2018 | $54,000 | +1250.0% | 20,915 | +945.8% | 0.00% | – |
| Q1 2018 | $4,000 | -86.7% | 2,000 | -86.7% | 0.00% | – |
| Q4 2017 | $30,000 | -26.8% | 14,986 | +17.5% | 0.00% | – |
| Q3 2017 | $41,000 | +57.7% | 12,758 | +59.5% | 0.00% | – |
| Q2 2017 | $26,000 | +44.4% | 8,000 | +23.1% | 0.00% | – |
| Q1 2017 | $18,000 | -47.1% | 6,500 | -55.3% | 0.00% | – |
| Q4 2016 | $34,000 | +1033.3% | 14,555 | +627.8% | 0.00% | – |
| Q3 2016 | $3,000 | -83.3% | 2,000 | -88.4% | 0.00% | – |
| Q2 2016 | $18,000 | +800.0% | 17,224 | +761.2% | 0.00% | – |
| Q1 2016 | $2,000 | -85.7% | 2,000 | -83.2% | 0.00% | – |
| Q4 2015 | $14,000 | -58.8% | 11,940 | -41.2% | 0.00% | – |
| Q3 2015 | $34,000 | +183.3% | 20,319 | +256.5% | 0.00% | – |
| Q2 2015 | $12,000 | -60.0% | 5,700 | -50.0% | 0.00% | – |
| Q1 2015 | $30,000 | -49.2% | 11,401 | -49.7% | 0.00% | – |
| Q4 2014 | $59,000 | – | 22,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |